ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Endothelial activation"

  • 2019 American Transplant Congress

    Novel Activation Responses by Endothelial Cells within the Pro-Tolerogenic Intragraft Microenvironment

    J. Wedel1, K. Liu1, P. T. Sage2, C. V. Carman3, P. Bobrowicz4, S. Kong5, B. McLaughlin4, D. M. Briscoe1

    1Transplant Research Program, Boston Children's Hospital, Boston, MA, 2Transplant Research Center, Brigham and Woman Hospital, Boston, MA, 3Harvard T.H. Chan School of Public Health, Boston, MA, 4Compass Therapeutics, Cambridge, MA, 5Computational Health Informatics Program, Boston Children's Hospital, Boston, MA

    *Purpose: Current paradigms indicate that endothelial cells (EC) within allografts participate in the initiation and progression of allograft rejection. However, little is known about their…
  • 2019 American Transplant Congress

    Ligation Of Hla Class Il Molecules Disrupts Endothelial Barrier Through Src-dependent Ve-cadherin Destabilization

    F. Li1, R. A. Sosa1, N. M. Valenzuela1, E. Rozengurt2, E. F. Reed1

    1Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, 2Digestive Diseases Research Center, University of California, Los Angeles, Los Angeles, CA

    *Purpose: Microvascular inflammation, vascular permeability, and accumulation of intravascular mononuclear cells are characteristics of acute and chronic antibody-mediated rejection. Vascular endothelial cadherin (VE-Cadherin) is a…
  • 2019 American Transplant Congress

    Single Cell RNA-seq Analysis of Antibody-Mediated Rejection Reveals Endothelial – Pericyte NOTCH Signaling

    A. F. Malone, A. Chadha, H. Wu, S. Ramakrishnan, E. Donnelly, B. D. Humphreys

    Washington University School of Medicine, Saint Louis, MO

    *Purpose: To precisely define endothelial cell responses in AMR we performed comprehensive single cell RNA-seq on a human kidney biopsy with AMR.*Methods: Single cell libraries…
  • 2019 American Transplant Congress

    A Novel Ex Vivo Normothermic Perfusion Model of Human Antibody Mediated Rejection

    P. Chandak1, B. L. Phillips1, R. Uwechue1, C. J. Callaghan1, O. Shaw2, T. Maggs3, L. Woodford3, D. Veniard3, R. Perera4, K. Parmar3, B. Hunt5, D. Bennett6, N. Kessaris1, A. Dorling7, N. Mamode1

    1Transplantation, Guy's and St Thomas Hospitals NHS Trust and King's College London, London, United Kingdom, 2Transplantation and CTL Laboratory, Guy's and St Thomas Hospitals NHS Trust and King's College London, London, United Kingdom, 3Haematology and Thrombosis, Guy's and St Thomas Hospitals NHS Trust, London, United Kingdom, 4Histopathology, Guy's and St Thomas Hospitals NHS Trust, London, United Kingdom, 5Haematology and Thrombosis, Guy's and St Thomas Hospitals NHS Trust and King's College London, London, United Kingdom, 6Interface Physics, University of Bristol, London, United Kingdom, 7Inflammation, Thrombosis and Repair and Transplantation, Guy's and St Thomas Hospitals NHS Trust and King's College London, London, United Kingdom

    *Purpose: Currently, no human experimental model of antibody-mediated rejection (AMR) exists, making the assessment of therapeutic interventions difficult hence the aim of our work is…
  • 2019 American Transplant Congress

    Differential Regulation of Phosphokinases by Anti-HLA Class I and 11 Antibodies

    A. Babu1, B. Tran2, M. Hamdorf2, V. Jucaud2, S. Daga3, D. Mitchell4, M. Everly2

    1Henry Ford Hospitals, Detroit, MI, 2Terasaki Research Institute, Los Angeles, CA, 3University of Warwick, Coventry, United Kingdom, 4Medical Sciences, University of Warwick, Coventry, United Kingdom

    *Purpose: Anti-HLA antibodies, both pre-formed and de novo are associated with worse graft survival. Glomerular endothelial cells are the targets for antibody mediated rejection. We…
  • 2018 American Transplant Congress

    Anti-Angiotensin II Type 1-Receptor Antibodies (AT1R-Ab) Induce a Specific Phenotype of Rejection Distinct from HLA Antibody-Mediated Rejection

    C. Lefaucheur,1 D. Viglietti,1 O. Aubert,1 A. Philippe,2 P. Halloran,3 A. Loupy,1 D. Dragun.2

    1Paris Translational Research Center for Organ Transplantation, Paris, France; 2Medical Faculty of the Charité, Berlin, Germany; 3Alberta Transplant Applied Genomics Centre, Edmonton, Canada.

    AT1R-Ab have been associated with kidney allograft rejection; however, their ability to induce a specific rejection phenotype, independent of HLA-DSAs, has not been defined.In a…
  • 2018 American Transplant Congress

    The Utility of a CD31/CD68 Dual Immunohistochemical Stain to Improve Accurate Diagnosis of Antibody Mediated Rejection in Cardiac Transplantation

    C. Glass, Y. Butt, T. Gokaslan, J. Torrealba.

    Thoracic Pathology, University of Texas Southwestern Medical Center, Dallas, TX.

    Antibody mediated rejection (AMR) occurs in 10%-20% of cardiac transplant patients and is associated with increased mortality. The endomyocardial biopsy, used to identify microvascular injury…
  • 2018 American Transplant Congress

    Endothelial Cell Heterogeneity Governs Basal and Inducible Inflammatory Responses Relevant to Allograft Injury

    N. Valenzuela.

    Pathology and Laboratory Medicine, UCLA, Los Angeles, CA.

    PurposeTransplanted tissues are differentially susceptible to ischemia/reperfusion and rejection. Endothelial cells (EC) are active regulators of inflammation. But model EC may not adequately reflect the…
  • 2018 American Transplant Congress

    Dual Inhibition of PI3K and mTORC2 Causes ERK Hyperactivation Induced by HLA-II Antibody in Human Endothelium

    Y-.P. Jin, E. Reed.

    Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA.

    Background: Endothelial cells (EC) line the inner surface of blood vessels and serve as the interface between recipient circulating blood and the donor allograft. Transplant…
  • 2018 American Transplant Congress

    Circulating Wnt Pathway Factors Are Non-Invasive Biomarkers of Transplant Vascular Injury

    M. Seifert,1 A. Malone,2 L. Boohaker,1 J. Gaut,2 S. Jain,2 D. Brennan,2,3 R. Mannon.1

    1UAB School of Medicine, Birmingham; 2Washington University, St. Louis; 3Johns Hopkins University, Baltimore.

    Purpose: Transplant vascular injury (TVI) is a major cause of renal allograft failure and is resistant to treatment. Non-invasive pathogenic biomarkers of TVI would provide…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences